Close
Help


Gene Expression in Post-Chemotherapy RB Tumors

Posted Fri, Sep, 20,2013

Published today in Bioinformatics and Biology Insights is a new original research article by Venkatesan Nalini, Ramya Segu, Perinkulam Ravi Deepa, Vikas Khetan, Madavan Vasudevan and Subramanian Krishnakumar.  Read more about this paper below:

Title

Molecular Insights on Post-chemotherapy Retinoblastoma by Microarray Gene Expression Analysis

Abstract

Purpose: Management of Retinoblastoma (RB), a pediatric ocular cancer is limited by drug-resistance and drug-dosage related side effects during chemotherapy. Molecular de-regulation in post-chemotherapy RB tumors was investigated.

Materials and Methods: cDNA microarray analysis of two post-chemotherapy and one pre-chemotherapy RB tumor tissues was performed, followed by Principle Component Analysis, Gene ontology, Pathway Enrichment analysis and Biological Analysis Network (BAN) modeling. The drug modulation role of two significantly up-regulated genes (P≤0.05) ― Ect2 (Epithelial-cell-transforming-sequence-2), and PRAME (preferentially-expressed-Antigen-in-Melanoma) was assessed by qRT-PCR, immunohistochemistry and cell viability assays.

Results: Differential up-regulation of 1672 genes and down-regulation of 2538 genes was observed in RB tissues (relative to normal adult retina), while 1419 genes were commonly de-regulated between pre-chemotherapy and post- chemotherapy RB. Twenty one key gene ontology categories, pathways, biomarkers and phenotype groups harboring 250 differentially expressed genes were dys-regulated (EZH2, NCoR1, MYBL2, RB1, STAMN1, SYK, JAK1/2, STAT1/2, PLK2/4, BIRC5, LAMN1, Ect2, PRAME and ABCC4). Differential molecular expressions of PRAME and Ect2 in RB tumors with and without chemotherapy were analyzed. There was neither up- regulation of MRP1, nor any significant shift in chemotherapeutic IC50, in PRAME over-expressed versus non-transfected RB cells.

Conclusion: Cell cycle regulatory genes were dys-regulated post-chemotherapy. Ect2 gene was expressed in response to chemotherapy-induced stress. PRAME does not contribute to drug resistance in RB, yet its nuclear localization and BAN information, points to its possible regulatory role in RB.

Click here to learn more about the article, download it and comment

share on

Posted in: Articles Published

  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Libertas Academica
testimonial_image
We found Bioinformatics and Biology insights very supportive and quick in guiding us in submitting our manuscript.  The review of the manuscript was also very prompt.  We also found that the review was fair and prompt and that was the most important thing for us. It was a very interesting experience for us. We also liked the video abstract service, which is very novel and encouraging for authors.
Dr S. Krishakumar (Vision Research Foundation, India)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube